Drug intelligence / Profile preview

Painenz

Development stage
Unknown
Lead developer
Emzor Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Painenz is a combination analgesic and antipyretic medication primarily composed of paracetamol (acetaminophen) and caffeine. Paracetamol exerts its therapeutic effects by inhibiting prostaglandin synthesis in the central nervous system, which provides relief from mild to moderate pain and reduces fever. Caffeine acts as an analgesic adjuvant by antagonizing adenosine receptors, which not only enhances the analgesic efficacy of paracetamol but also increases its rate of absorption and provides mild vasoconstrictive properties that are particularly beneficial for treating headaches and migraines. Developed and manufactured by Emzor Pharmaceuticals, Painenz is widely utilized for the symptomatic relief of various conditions, including headaches, muscle aches, menstrual cramps, and toothaches.

Brand names
Painenz
Other names
paracetamol + caffeine
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Painenz.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Painenz.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call